April 24, 2026Journal of the American College of Cardiology
Thoracic Aortic Aneurysm and Dissection
Key result
Review outlines risk factors, genetics, and management strategies for thoracic aortic aneurysm and dissection.
Why the study?
Aortic dissection is the most devastating complication of thoracic aortic disease, prompting a review of clinical insights and management strategies learned since it was first described.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Informs clinical decision-making in thoracic aortic aneurysm and dissection; leaves open specific genetic and inflammatory pathways for further investigation.
Key Points
- The review aims to summarize current knowledge on thoracic aortic dissection, its risk factors, and therapeutic approaches.
- Reviewed literature on thoracic aortic diseases over 250 years
- Examined genetic and inflammatory risk factors
- Discussed medical and surgical management options
- Identified genetic conditions like Marfan syndrome that increase risk of dissection
- Confirmed effectiveness of beta-blockers and ACE inhibitors in managing aneurysms
- Reviewed surgical techniques and endovascular management options for different aortic segments
Structured PICO
P
Population
Patients with or at risk for thoracic aortic aneurysm and dissection
I
Intervention
Medical therapies (beta-blockers, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors), prophylactic surgery, and endovascular management
This review provides a comprehensive overview of thoracic aortic aneurysm and dissection, covering risk factors, genetics, medical therapies, and surgical management.
Cite This Study
Goldfinger et al. (2014) conducted a review in Thoracic Aortic Aneurysm and Dissection. This review summarizes risk factors, genetic underpinnings, medical therapies, and surgical management strategies for thoracic aortic aneurysm and dissection.